Biomarin Pharmaceutical (BMRN) Q3 2016 Earnings

4AugConfirmed
Q4 2015
Q1 2016
Q2 2016
Q3 2016
-0.68
-0.09
0.51
1.1

Details

Expected EPS
-0.51
Actual EPS
1.08
Surprise EPS
1.59
Surprise Percent
+311.76%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of 1.08 per share for Q3 2016.

0 Comments

Share your thoughts